Clinical trial
Glycaemic and Cardiovascular Efficacy of Liraglutide in Prediabetic Patients With End-stage Renal Disease
NCT02284230 is registered in ClinicalTrials.gov with Bo Feldt-Rasmussen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Glycaemic and Cardiovascular Efficacy of Liraglutide in Prediabetic Patients With End-stage Renal Disease
- Lead sponsor
- Bo Feldt-Rasmussen
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- December 31, 2014
- Completion date
- August 31, 2015
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.